ArticleClinicoEconomics and outcomes research : CEOR2025
Cost-Utility Analysis of Renal Replacement Therapy Modalities in the Management of Severe Acute Kidney Injury in US Critically Ill Patients.
Rui Martins et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.